Mette Kirstine Agger's Insider Trades & SAST Disclosures

Mette Kirstine Agger's most recent trade in Lexeo Therapeutics Inc. was a trade of 18,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 25, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lexeo Therapeutics Inc.
Mette Kirstine Agger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2024 18,000 18,000 - - Stock Option (right to buy)
scPharmaceuticals Inc
Mette Kirstine Agger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 19,750 19,750 - - Stock Option (Right to Buy)
Lexeo Therapeutics Inc.
Kirstine Mette Agger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2024 36,000 36,000 - - Stock Option (right to buy)
scPharmaceuticals Inc
Mette Kirstine Agger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,300 17,300 - - Stock Option (Right to Buy)
scPharmaceuticals Inc
Mette Kirstine Agger None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2020 6,124 6,124 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades